Table of Contents Author Guidelines Submit a Manuscript
Multiple Sclerosis International
Volume 2013, Article ID 319201, 9 pages
http://dx.doi.org/10.1155/2013/319201
Research Article

Adding to the Burden: Gastrointestinal Symptoms and Syndromes in Multiple Sclerosis

1Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Pittsburgh Medical Center, S848 Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 15261, USA
2Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA 15261, USA
3Division of Gastroenterology, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA
4Neuroimmunology/Multiple Sclerosis Division, Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, PA 15261, USA

Received 12 June 2013; Accepted 14 August 2013

Academic Editor: Mark S. Freedman

Copyright © 2013 David J. Levinthal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. F. Kurtzke, “Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS),” Neurology, vol. 33, no. 11, pp. 1444–1452, 1983. View at Google Scholar · View at Scopus
  2. R. Bergamaschi, P. Crivelli, C. Rezzani et al., “The DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis,” Journal of the Neurological Sciences, vol. 269, no. 1-2, pp. 49–53, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Nusrat, E. Gulick, D. Levinthal, and K. Bielefeldt, “Anorectal dysfunction in multiple sclerosis: a systematic review,” ISRN Neurology, vol. 2012, Article ID 376023, 9 pages, 2012. View at Publisher · View at Google Scholar
  4. J. P. Hinds, B. H. Eidelman, and A. Wald, “Prevalence of bowel dysfunction in multiple sclerosis. A population Survey,” Gastroenterology, vol. 98, no. 6, pp. 1538–1542, 1990. View at Google Scholar · View at Scopus
  5. M. Alkhawajah and J. Oger, “When to initiate disease-modifying drugs for relapsing remitting multiple sclerosis in adults?” Multiple Sclerosis International, vol. 2011, Article ID 724871, 11 pages, 2011. View at Publisher · View at Google Scholar
  6. J. Hobart, D. Lamping, R. Fitzpatrick, A. Riazi, and A. Thompson, “The multiple sclerosis impact scale (MSIS-29) a new patient-based outcome measure,” Brain, vol. 124, no. 5, pp. 962–973, 2001. View at Google Scholar · View at Scopus
  7. D. A. Drossman, “The functional gastrointestinal disorders and the Rome III process,” in Rome III: The Functional Gastrointestinal Disorders, D. A. Drossman, E. Corazziari, M. Delvaux et al., Eds., pp. 1–29, Degnon Associates, McLean, Va, USA, 3rd edition, 2006. View at Google Scholar
  8. A. Y. Chen, R. Frankowshi, J. Bishop-Leone et al., “The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory,” Archives of Otolaryngology—Head and Neck Surgery, vol. 127, no. 7, pp. 870–876, 2001. View at Google Scholar · View at Scopus
  9. T. H. Rockwood, J. M. Church, J. W. Fleshman et al., “Patient and surgeon ranking of the severity of symptoms associated with fecal incontinence: the fecal incontinence severity index,” Diseases of the Colon and Rectum, vol. 42, no. 12, pp. 1525–1532, 1999. View at Google Scholar · View at Scopus
  10. R. Kumar, “Approved and investigational uses of modafinil: an evidence-based review,” Drugs, vol. 68, no. 13, pp. 1803–1839, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Mcdonald and J. N. Clements, “Dalfampridine: a new agent for symptomatic management of multiple sclerosis,” American Journal of Health-System Pharmacy, vol. 68, no. 24, pp. 2335–2340, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. E. B. Blanchard, L. Scharff, S. P. Schwarz, J. M. Suls, and D. H. Barlow, “The role of anxiety and depression in the irritable bowel syndrome,” Behaviour Research and Therapy, vol. 28, no. 5, pp. 401–405, 1990. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Henningsen, T. Zimmermann, and H. Sattel, “Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review,” Psychosomatic Medicine, vol. 65, no. 4, pp. 528–533, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. L. van Oudenhove, J. Vandenberghe, R. Vos, B. Fischler, K. Demyttenaere, and J. Tack, “Abuse history, depression, and somatization are associated with gastric sensitivity and gastric emptying in functional dyspepsia,” Psychosomatic Medicine, vol. 73, no. 8, pp. 648–655, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. L. D. Wood, J. J. Neumiller, S. M. Setter, and E. K. Dobbins, “Clinical review of treatment options for select nonmotor symptoms of Parkinson's disease,” The American Journal Geriatric Pharmacotherapy, vol. 8, no. 4, pp. 294–315, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. R. F. Pfeiffer, “Gastrointestinal dysfunction in Parkinson's disease,” Parkinsonism and Related Disorders, vol. 17, no. 1, pp. 10–15, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Tang, E. L. Dimberg, M. Milone, and L. J. C. Wong, “Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)-like phenotype: an expanded clinical spectrum of POLG1 mutations,” Journal of Neurology, vol. 259, no. 5, pp. 862–868, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Isono, M. Hirano, H. Sakamoto, S. Ueno, S. Kusunoki, and Y. Nakamura, “Differences in Dysphagia between spinocerebellar ataxia type 3 and type 6,” Dysphagia, vol. 28, no. 3, pp. 413–418, 2013. View at Google Scholar
  19. L. Rofes, N. Vilardell, and P. Clavé, “Post-stroke dysphagia: progress at last,” Neurogastroenterology & Motility, vol. 25, pp. 278–282, 2013. View at Google Scholar
  20. N. J. Donovan, S. K. Daniels, J. Edmiaston et al., “Dysphagia screening: state of the art: invitational conference proceeding from the State-of-the-Art Nursing Symposium, International Stroke Conference 2012,” Stroke, vol. 44, no. 4, pp. e24–e31, 2013. View at Publisher · View at Google Scholar
  21. A. Hennessey, N. P. Robertson, R. Swingler, and D. A. Compston, “Urinary, faecal and sexual dysfunction in patients with multiple sclerosis,” Journal of Neurology, vol. 246, no. 11, pp. 1027–1032, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. R. DasGupta and C. J. Fowler, “Bladder, bowel and sexual dysfunction in multiple sclerosis: management strategies,” Drugs, vol. 63, no. 2, pp. 153–166, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. C. K. Porter, R. Gormley, D. R. Tribble, B. D. Cash, and M. S. Riddle, “The incidence and gastrointestinal infectious risk of functional gastrointestinal disorders in a healthy US adult population,” American Journal of Gastroenterology, vol. 106, no. 1, pp. 130–138, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Y. Chang, G. R. Locke III, M. A. McNally et al., “Impact of functional gastrointestinal disorders on survival in the community,” American Journal of Gastroenterology, vol. 105, no. 4, pp. 822–832, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. G. R. Locke III, A. R. Zinsmeister, S. L. Fett, L. J. Melton III, and N. J. Talley, “Overlap of gastrointestional symptom complexes in a US community,” Neurogastroenterology and Motility, vol. 17, no. 1, pp. 29–34, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Poorjavad, F. Derakhshandeh, M. Etemadifar, B. Soleymani, A. Minagar, and A.-H. Maghzi, “Oropharyngeal dysphagia in multiple sclerosis,” Multiple Sclerosis, vol. 16, no. 3, pp. 362–365, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Bergamaschi, C. Rezzani, S. Minguzzi et al., “Validation of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis,” Functional Neurology, vol. 24, no. 3, pp. 159–162, 2009. View at Google Scholar · View at Scopus
  28. S. Nusrat, S. Nusrat, and K. Bielefeldt, “Reflux and sex: what drives testing, what drives treatment?” European Journal of Gastroenterology and Hepatology, vol. 24, no. 3, pp. 233–247, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Sørensen, M. Lorentzen, J. Petersen, and J. Christiansen, “Anorectal dysfunction in patients with urologic disturbance due to multiple sclerosis,” Diseases of the Colon and Rectum, vol. 34, no. 2, pp. 136–139, 1991. View at Google Scholar · View at Scopus
  30. G. Chiarioni, L. Salandini, and W. E. Whitehead, “Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation,” Gastroenterology, vol. 129, no. 1, pp. 86–97, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Weber, P. Grise, M. Roquebert et al., “Radiopaque markers transit and anorectal manometry in 16 patients with multiple sclerosis and urinary bladder dysfunction,” Diseases of the Colon and Rectum, vol. 30, no. 2, pp. 95–100, 1987. View at Google Scholar · View at Scopus
  32. S. E. Mathers, D. A. Ingram, and M. Swash, “Electrophysiology of motor pathways for sphincter control in multiple sclerosis,” Journal of Neurology Neurosurgery and Psychiatry, vol. 53, no. 11, pp. 955–960, 1990. View at Google Scholar · View at Scopus
  33. D. J. Waldron, P. G. Horgan, F. R. Patel, R. Maguire, and H. F. Given, “Multiple sclerosis: assessment of colonic and anorectal function in the presence of faecal incontinence,” International Journal of Colorectal Disease, vol. 8, no. 4, pp. 220–224, 1993. View at Publisher · View at Google Scholar · View at Scopus
  34. Y.-W. Chia, C. J. Fowler, M. A. Kamm, M. M. Henry, M. C. Lemieux, and M. Swash, “Prevalence of bowel dysfunction in patients with multiple sclerosis and bladder dysfunction,” Journal of Neurology, vol. 242, no. 2, pp. 105–108, 1995. View at Publisher · View at Google Scholar · View at Scopus
  35. A. M. Nordenbo, J. R. Andersen, and J. T. Andersen, “Disturbances of ano-rectal function in multiple sclerosis,” Journal of Neurology, vol. 243, no. 6, pp. 445–451, 1996. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Shahid, Z. Ramzan, A. H. Maurer, H. P. Parkman, and R. S. Fisher, “Chronic idiopathic constipation: more than a simple colonic transit disorder,” Journal of Clinical Gastroenterology, vol. 46, no. 2, pp. 150–154, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. W. E. Whitehead, L. Borrud, P. S. Goode et al., “Fecal Incontinence in US Adults: epidemiology and risk factors,” Gastroenterology, vol. 137, no. 2, pp. 512–517, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. A. D. Mak, J. C. Wu, Y. Chan, F. K. Chan, J. J. Sung, and S. Lee, “Dyspepsia is strongly associated with major depression and generalised anxiety disorder: a community study,” Alimentary Pharmacology & Therapeutics, vol. 36, pp. 800–810, 2012. View at Google Scholar
  39. B. F. Popescu, V. A. Lennon, J. E. Parisi et al., “Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications,” Neurology, vol. 76, no. 14, pp. 1229–1237, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. S. C. Reddymasu, J. Bonino, and R. W. McCallum, “Gastroparesis secondary to a demyelinating disease: a case series,” BMC Gastroenterology, vol. 7, article 3, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Raghav, D. Kipp, J. Watson, and W. Spring, “Gastroparesis with multiple sclerosis,” Multiple Sclerosis, vol. 12, no. 2, pp. 243–244, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. P. J. Jongen, C. Sindic, E. Sanders et al., “Adverse events of interferon beta-1a: a prospective multi-centre international ICH-GCP-based CRO-supported external validation study in daily practice,” PLoS One, vol. 6, no. 10, Article ID e26568, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. P. O'Connor, J. S. Wolinsky, C. Confavreux et al., “Randomized trial of oral teriflunomide for relapsing multiple sclerosis,” The New England Journal of Medicine, vol. 365, no. 14, pp. 1293–1303, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Truini, F. Galeotti, S. La Cesa et al., “Mechanisms of pain in multiple sclerosis: a combined clinical and neurophysiological study,” Pain, vol. 153, pp. 2048–2054, 2012. View at Google Scholar
  45. S. Elsenbruch, C. Rosenberger, U. Bingel, M. Forsting, M. Schedlowski, and E. R. Gizewski, “Patients with irritable bowel syndrome have altered emotional modulation of neural responses to visceral stimuli,” Gastroenterology, vol. 139, no. 4, pp. 1310–1319, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. B. D. Naliboff, J. Munakata, S. Fullerton et al., “Evidence for two distinct perceptual alterations in irritable bowel syndrome,” Gut, vol. 41, no. 4, pp. 505–512, 1997. View at Google Scholar · View at Scopus
  47. R. S. Choung, G. R. Locke III, A. R. Zinsmeister, C. D. Schleck, and N. J. Talley, “Psychosocial distress and somatic symptoms in community subjects with irritable bowel syndrome: a psychological component is the rule,” American Journal of Gastroenterology, vol. 104, no. 7, pp. 1772–1779, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. J. M. Lackner and B. M. Quigley, “Pain catastrophizing mediates the relationship between worry and pain suffering in patients with irritable bowel syndrome,” Behaviour Research and Therapy, vol. 43, no. 7, pp. 943–957, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Sjonnesen, S. Berzins, K. M. Fiest et al., “Evaluation of the 9-item patient health questionnaire (PHQ-9) as an assessment instrument for symptoms of depression in patients with multiple sclerosis,” Postgraduate Medical, vol. 124, pp. 69–77, 2012. View at Google Scholar
  50. P. Moore, C. Hirst, K. E. Harding, H. Clarkson, T. P. Pickersgill, and N. P. Robertson, “Multiple sclerosis relapses and depression,” Journal of Psychosomatic Research, vol. 73, pp. 272–276, 2012. View at Google Scholar
  51. L. B. Strober, C. Christodoulou, R. H. Benedict et al., “Unemployment in multiple sclerosis: the contribution of personality and disease,” Multiple Sclerosis, vol. 18, no. 5, pp. 647–653, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Krokavcova, I. Nagyova, J. Rosenberger et al., “Employment status and perceived health status in younger and older people with multiple sclerosis,” International Journal of Rehabilitation Research, vol. 35, no. 1, pp. 40–47, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. J. M. Sonder, L. Bosma, F. A. H. van der Linden, D. L. Knol, C. H. Polman, and B. M. J. Uitdehaag, “Proxy measurements in multiple sclerosis: agreement on different patient-reported outcome scales,” Multiple Sclerosis, vol. 18, no. 2, pp. 196–201, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. L. Bosma, J. Kragt, C. Polman et al., “Walking speed, rather than expanded disability status scale, relates to long-term patient-reported impact in progressive MS,” Multiple Sclerosis Journal, vol. 19, pp. 326–333, 2013. View at Google Scholar
  55. R. W. Motl, E. McAuley, D. Wynn, B. Sandroff, and Y. Suh, “Physical activity, self-efficacy, and health-related quality of life in persons with multiple sclerosis: analysis of associations between individual-level changes over one year,” Quality of Life Research, vol. 22, no. 2, pp. 253–261, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. K. Jones, D. Ford, P. Jones et al., “The physical and psychological impact of multiple sclerosis using the MSIS-29 via the web portal of the UK MS register,” PLoS One, vol. 8, Article ID e55422, 2013. View at Google Scholar
  57. F. Chang, P. Chen, T. Wu et al., “Prevalence of functional gastrointestinal disorders in Taiwan: questionnaire-based survey for adults based on the Rome III criteria,” Asia Pacific Journal of Clinical Nutrition, vol. 21, pp. 594–600, 2012. View at Google Scholar
  58. P. Aro, N. J. Talley, L. Agréus et al., “Functional dyspepsia impairs quality of life in the adult population,” Alimentary Pharmacology and Therapeutics, vol. 33, no. 11, pp. 1215–1224, 2011. View at Publisher · View at Google Scholar · View at Scopus